yes that is our CSO: Dr. Chappell began his career as a Howard Hughes Medical Institute fellow at the National Cancer Institute where he studied tumor immunology and published in the field of T-cell therapy, immunology pathways, and GM-CSF, giving him clear insights into the development and execution of our business strategy. He is also the founder of Black Horse Capital with decades of biotechnology investment experience. https://www.otcmarkets.com/stock/HGEN/news/Humanigen-Appoints-Senior-Executives-to-Management-Team?id=266880